BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221103T180000
DTEND;TZID=America/Vancouver:20221106T190000
DTSTAMP:20260403T182205
CREATED:20220929T225934Z
LAST-MODIFIED:20220929T225934Z
UID:24262-1667498400-1667761200@scienceinvancouver.com
SUMMARY:9th TFRI Scientific Meeting
DESCRIPTION:The Terry Fox Research Institute is pleased to announce the return of its scientific meeting in November 2022\, with an expanded agenda and more attendees to welcome a new community of funded researchers as well as returning ones!  \nThe theme for this year’s meeting is Cancer Research: Past\, Present and Future. Our Scientific Organizing Committee is in the midst of developing the scientific program for the meeting right now! \nThis meeting will be at the Vancouver Convention Centre (VCC) West Nov. 3-6 (including travel dates)\, commencing with registration Nov. 3 (evening) and the meeting on Friday Nov. 4 and Saturday Nov. 5. There will be a tribute to TFRI’s Founding President and Scientific Director Dr. Victor Ling at a dinner celebration on the evening of Nov. 5. TFRI will follow COVID protocols in place at the time of meeting. \nTFRI organizes a Scientific Meeting (SM) as an opportunity for the whole community of Terry Fox-funded researchers to get together to share ideas and to discuss their research. The meeting is by invitation only. Our meeting this year will be a two-day session consisting of several plenaries\, poster presentations and rapid-fire talks as well as breakouts. We will conclude with a celebratory dinner in recognition of Dr. Victor Ling’s contribution to TFRI over 15 years. Registration for this event is by-invitation only.
URL:https://scienceinvancouver.com/event/9th-tfri-scientific-meeting/
LOCATION:Vancouver Convention Centre\, 1055 Canada Place\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221103T180000
DTEND;TZID=America/Vancouver:20221106T190000
DTSTAMP:20260403T182205
CREATED:20220929T225934Z
LAST-MODIFIED:20220929T225934Z
UID:26601-1667498400-1667761200@scienceinvancouver.com
SUMMARY:9th TFRI Scientific Meeting
DESCRIPTION:The Terry Fox Research Institute is pleased to announce the return of its scientific meeting in November 2022\, with an expanded agenda and more attendees to welcome a new community of funded researchers as well as returning ones!  \nThe theme for this year’s meeting is Cancer Research: Past\, Present and Future. Our Scientific Organizing Committee is in the midst of developing the scientific program for the meeting right now! \nThis meeting will be at the Vancouver Convention Centre (VCC) West Nov. 3-6 (including travel dates)\, commencing with registration Nov. 3 (evening) and the meeting on Friday Nov. 4 and Saturday Nov. 5. There will be a tribute to TFRI’s Founding President and Scientific Director Dr. Victor Ling at a dinner celebration on the evening of Nov. 5. TFRI will follow COVID protocols in place at the time of meeting. \nTFRI organizes a Scientific Meeting (SM) as an opportunity for the whole community of Terry Fox-funded researchers to get together to share ideas and to discuss their research. The meeting is by invitation only. Our meeting this year will be a two-day session consisting of several plenaries\, poster presentations and rapid-fire talks as well as breakouts. We will conclude with a celebratory dinner in recognition of Dr. Victor Ling’s contribution to TFRI over 15 years. Registration for this event is by-invitation only.
URL:https://scienceinvancouver.com/event/9th-tfri-scientific-meeting-2/
LOCATION:Vancouver Convention Centre\, 1055 Canada Place\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221103T180000
DTEND;TZID=America/Vancouver:20221106T190000
DTSTAMP:20260403T182205
CREATED:20220929T225934Z
LAST-MODIFIED:20220929T225934Z
UID:28216-1667498400-1667761200@scienceinvancouver.com
SUMMARY:9th TFRI Scientific Meeting
DESCRIPTION:The Terry Fox Research Institute is pleased to announce the return of its scientific meeting in November 2022\, with an expanded agenda and more attendees to welcome a new community of funded researchers as well as returning ones!  \nThe theme for this year’s meeting is Cancer Research: Past\, Present and Future. Our Scientific Organizing Committee is in the midst of developing the scientific program for the meeting right now! \nThis meeting will be at the Vancouver Convention Centre (VCC) West Nov. 3-6 (including travel dates)\, commencing with registration Nov. 3 (evening) and the meeting on Friday Nov. 4 and Saturday Nov. 5. There will be a tribute to TFRI’s Founding President and Scientific Director Dr. Victor Ling at a dinner celebration on the evening of Nov. 5. TFRI will follow COVID protocols in place at the time of meeting. \nTFRI organizes a Scientific Meeting (SM) as an opportunity for the whole community of Terry Fox-funded researchers to get together to share ideas and to discuss their research. The meeting is by invitation only. Our meeting this year will be a two-day session consisting of several plenaries\, poster presentations and rapid-fire talks as well as breakouts. We will conclude with a celebratory dinner in recognition of Dr. Victor Ling’s contribution to TFRI over 15 years. Registration for this event is by-invitation only.
URL:https://scienceinvancouver.com/event/9th-tfri-scientific-meeting-3/
LOCATION:Vancouver Convention Centre\, 1055 Canada Place\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221103T180000
DTEND;TZID=America/Vancouver:20221106T190000
DTSTAMP:20260403T182205
CREATED:20220929T225934Z
LAST-MODIFIED:20220929T225934Z
UID:31299-1667498400-1667761200@scienceinvancouver.com
SUMMARY:9th TFRI Scientific Meeting
DESCRIPTION:The Terry Fox Research Institute is pleased to announce the return of its scientific meeting in November 2022\, with an expanded agenda and more attendees to welcome a new community of funded researchers as well as returning ones!  \nThe theme for this year’s meeting is Cancer Research: Past\, Present and Future. Our Scientific Organizing Committee is in the midst of developing the scientific program for the meeting right now! \nThis meeting will be at the Vancouver Convention Centre (VCC) West Nov. 3-6 (including travel dates)\, commencing with registration Nov. 3 (evening) and the meeting on Friday Nov. 4 and Saturday Nov. 5. There will be a tribute to TFRI’s Founding President and Scientific Director Dr. Victor Ling at a dinner celebration on the evening of Nov. 5. TFRI will follow COVID protocols in place at the time of meeting. \nTFRI organizes a Scientific Meeting (SM) as an opportunity for the whole community of Terry Fox-funded researchers to get together to share ideas and to discuss their research. The meeting is by invitation only. Our meeting this year will be a two-day session consisting of several plenaries\, poster presentations and rapid-fire talks as well as breakouts. We will conclude with a celebratory dinner in recognition of Dr. Victor Ling’s contribution to TFRI over 15 years. Registration for this event is by-invitation only.
URL:https://scienceinvancouver.com/event/9th-tfri-scientific-meeting-4/
LOCATION:Vancouver Convention Centre\, 1055 Canada Place\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221103T180000
DTEND;TZID=America/Vancouver:20221106T190000
DTSTAMP:20260403T182205
CREATED:20220929T225934Z
LAST-MODIFIED:20220929T225934Z
UID:32759-1667498400-1667761200@scienceinvancouver.com
SUMMARY:9th TFRI Scientific Meeting
DESCRIPTION:The Terry Fox Research Institute is pleased to announce the return of its scientific meeting in November 2022\, with an expanded agenda and more attendees to welcome a new community of funded researchers as well as returning ones!  \nThe theme for this year’s meeting is Cancer Research: Past\, Present and Future. Our Scientific Organizing Committee is in the midst of developing the scientific program for the meeting right now! \nThis meeting will be at the Vancouver Convention Centre (VCC) West Nov. 3-6 (including travel dates)\, commencing with registration Nov. 3 (evening) and the meeting on Friday Nov. 4 and Saturday Nov. 5. There will be a tribute to TFRI’s Founding President and Scientific Director Dr. Victor Ling at a dinner celebration on the evening of Nov. 5. TFRI will follow COVID protocols in place at the time of meeting. \nTFRI organizes a Scientific Meeting (SM) as an opportunity for the whole community of Terry Fox-funded researchers to get together to share ideas and to discuss their research. The meeting is by invitation only. Our meeting this year will be a two-day session consisting of several plenaries\, poster presentations and rapid-fire talks as well as breakouts. We will conclude with a celebratory dinner in recognition of Dr. Victor Ling’s contribution to TFRI over 15 years. Registration for this event is by-invitation only.
URL:https://scienceinvancouver.com/event/9th-tfri-scientific-meeting-5/
LOCATION:Vancouver Convention Centre\, 1055 Canada Place\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221102T020000
DTEND;TZID=America/Vancouver:20221103T100000
DTSTAMP:20260403T182205
CREATED:20220916T214011Z
LAST-MODIFIED:20220916T214011Z
UID:32754-1667354400-1667469600@scienceinvancouver.com
SUMMARY:Invest in BC Presented by Lumira Ventures
DESCRIPTION:Life Sciences BC is excited to announce the 7th annual Invest in BC presented by Lumira Ventures\, taking place on November 2nd & 3rd\, 2022. \n\n\n\n\nInvest in BC presented by Lumira Ventures is an opportunity to bring together stakeholders in the healthcare innovation ecosystem. The two-day event includes company pitches\, presentations\, and panel discussion\, giving entrepreneurs a platform to share their stories and receive feedback and engagement from a wide range of investor stakeholders. Investor participants range from angel investors\, venture capital\, corporate venture\, and foundations. Life Sciences BC is very excited to once again offer this chance for companies to pitch their projects\, attract attention\, solicit support\, and secure investment that will aid them in their continued growth trajectory. \nEvent Details: \nDate: November 2nd & 3rd\, 2022 \nTime: 9:00 AM – 5:00 PM each day \nLocation: Virtual \n\n\n\n\nCheck back soon to see which BC companies will be pitching at this year’s event!
URL:https://scienceinvancouver.com/event/invest-in-bc-presented-by-lumira-ventures-2-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/Main-Graphic.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221102T020000
DTEND;TZID=America/Vancouver:20221103T100000
DTSTAMP:20260403T182205
CREATED:20220916T214011Z
LAST-MODIFIED:20220916T214011Z
UID:24093-1667354400-1667469600@scienceinvancouver.com
SUMMARY:Invest in BC Presented by Lumira Ventures
DESCRIPTION:Life Sciences BC is excited to announce the 7th annual Invest in BC presented by Lumira Ventures\, taking place on November 2nd & 3rd\, 2022. \n\n\n\n\nInvest in BC presented by Lumira Ventures is an opportunity to bring together stakeholders in the healthcare innovation ecosystem. The two-day event includes company pitches\, presentations\, and panel discussion\, giving entrepreneurs a platform to share their stories and receive feedback and engagement from a wide range of investor stakeholders. Investor participants range from angel investors\, venture capital\, corporate venture\, and foundations. Life Sciences BC is very excited to once again offer this chance for companies to pitch their projects\, attract attention\, solicit support\, and secure investment that will aid them in their continued growth trajectory. \nEvent Details: \nDate: November 2nd & 3rd\, 2022 \nTime: 9:00 AM – 5:00 PM each day \nLocation: Virtual \n\n\n\n\nCheck back soon to see which BC companies will be pitching at this year’s event!
URL:https://scienceinvancouver.com/event/invest-in-bc-presented-by-lumira-ventures-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/Main-Graphic.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221102T020000
DTEND;TZID=America/Vancouver:20221103T100000
DTSTAMP:20260403T182205
CREATED:20220916T214011Z
LAST-MODIFIED:20220916T214011Z
UID:26596-1667354400-1667469600@scienceinvancouver.com
SUMMARY:Invest in BC Presented by Lumira Ventures
DESCRIPTION:Life Sciences BC is excited to announce the 7th annual Invest in BC presented by Lumira Ventures\, taking place on November 2nd & 3rd\, 2022. \n\n\n\n\nInvest in BC presented by Lumira Ventures is an opportunity to bring together stakeholders in the healthcare innovation ecosystem. The two-day event includes company pitches\, presentations\, and panel discussion\, giving entrepreneurs a platform to share their stories and receive feedback and engagement from a wide range of investor stakeholders. Investor participants range from angel investors\, venture capital\, corporate venture\, and foundations. Life Sciences BC is very excited to once again offer this chance for companies to pitch their projects\, attract attention\, solicit support\, and secure investment that will aid them in their continued growth trajectory. \nEvent Details: \nDate: November 2nd & 3rd\, 2022 \nTime: 9:00 AM – 5:00 PM each day \nLocation: Virtual \n\n\n\n\nCheck back soon to see which BC companies will be pitching at this year’s event!
URL:https://scienceinvancouver.com/event/invest-in-bc-presented-by-lumira-ventures-2-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/Main-Graphic.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221102T020000
DTEND;TZID=America/Vancouver:20221103T100000
DTSTAMP:20260403T182205
CREATED:20220916T214011Z
LAST-MODIFIED:20220916T214011Z
UID:28211-1667354400-1667469600@scienceinvancouver.com
SUMMARY:Invest in BC Presented by Lumira Ventures
DESCRIPTION:Life Sciences BC is excited to announce the 7th annual Invest in BC presented by Lumira Ventures\, taking place on November 2nd & 3rd\, 2022. \n\n\n\n\nInvest in BC presented by Lumira Ventures is an opportunity to bring together stakeholders in the healthcare innovation ecosystem. The two-day event includes company pitches\, presentations\, and panel discussion\, giving entrepreneurs a platform to share their stories and receive feedback and engagement from a wide range of investor stakeholders. Investor participants range from angel investors\, venture capital\, corporate venture\, and foundations. Life Sciences BC is very excited to once again offer this chance for companies to pitch their projects\, attract attention\, solicit support\, and secure investment that will aid them in their continued growth trajectory. \nEvent Details: \nDate: November 2nd & 3rd\, 2022 \nTime: 9:00 AM – 5:00 PM each day \nLocation: Virtual \n\n\n\n\nCheck back soon to see which BC companies will be pitching at this year’s event!
URL:https://scienceinvancouver.com/event/invest-in-bc-presented-by-lumira-ventures-2-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/Main-Graphic.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221102T020000
DTEND;TZID=America/Vancouver:20221103T100000
DTSTAMP:20260403T182205
CREATED:20220916T214011Z
LAST-MODIFIED:20220916T214011Z
UID:31294-1667354400-1667469600@scienceinvancouver.com
SUMMARY:Invest in BC Presented by Lumira Ventures
DESCRIPTION:Life Sciences BC is excited to announce the 7th annual Invest in BC presented by Lumira Ventures\, taking place on November 2nd & 3rd\, 2022. \n\n\n\n\nInvest in BC presented by Lumira Ventures is an opportunity to bring together stakeholders in the healthcare innovation ecosystem. The two-day event includes company pitches\, presentations\, and panel discussion\, giving entrepreneurs a platform to share their stories and receive feedback and engagement from a wide range of investor stakeholders. Investor participants range from angel investors\, venture capital\, corporate venture\, and foundations. Life Sciences BC is very excited to once again offer this chance for companies to pitch their projects\, attract attention\, solicit support\, and secure investment that will aid them in their continued growth trajectory. \nEvent Details: \nDate: November 2nd & 3rd\, 2022 \nTime: 9:00 AM – 5:00 PM each day \nLocation: Virtual \n\n\n\n\nCheck back soon to see which BC companies will be pitching at this year’s event!
URL:https://scienceinvancouver.com/event/invest-in-bc-presented-by-lumira-ventures-2-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/09/Main-Graphic.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221027T160000
DTEND;TZID=America/Vancouver:20221027T183000
DTSTAMP:20260403T182205
CREATED:20221027T164740Z
LAST-MODIFIED:20221027T164740Z
UID:24628-1666886400-1666895400@scienceinvancouver.com
SUMMARY:D.R.I.N.K.S. Vancouver
DESCRIPTION:The D.R.I.N.K.S. (Discussions Relevant to Inspiring New Knowledge and Science) social is held monthly at Mahoneys on Stamps Landing (Old Monk Mcqueens on False Creek at 601 Stamps Landing – http://mahonyandsons.com/). The purpose is to bring together faculty\, clinicians\, engineers\, nurses\, physio/rehab\, scientists\, residents\, trainees\, staff\, entrepreneurs\, bio/pharm/hospital staff/execs/veterans\, lawyers\, VCs\, journalists/editors\, philanthropists\, visiting scientists\, those on sabbaticals\, and others with common interests in biomedical/translational research & discovery/commercialization once a month to casually interact and meet new people over a beverage of their choice and/or appie. It’s a great way for people that have just moved to\, just visiting Vancouver\, looking for collaborations\, jobs\, funding\, connections for start-ups\, networking/socializing to meet others in medicine/research/bioengineering/industry. All are welcome! \nThis event’s sponsor is Blakes. Blakes has provided legal counsel for many in the life sciences industry and has been a great supporter of the BC Biotech landscape for many years.
URL:https://scienceinvancouver.com/event/d-r-i-n-k-s-vancouver-5/
LOCATION:Mahony and Sons\, 601 Stamps Landing\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221027T160000
DTEND;TZID=America/Vancouver:20221027T183000
DTSTAMP:20260403T182205
CREATED:20221027T164740Z
LAST-MODIFIED:20221027T164740Z
UID:26609-1666886400-1666895400@scienceinvancouver.com
SUMMARY:D.R.I.N.K.S. Vancouver
DESCRIPTION:The D.R.I.N.K.S. (Discussions Relevant to Inspiring New Knowledge and Science) social is held monthly at Mahoneys on Stamps Landing (Old Monk Mcqueens on False Creek at 601 Stamps Landing – http://mahonyandsons.com/). The purpose is to bring together faculty\, clinicians\, engineers\, nurses\, physio/rehab\, scientists\, residents\, trainees\, staff\, entrepreneurs\, bio/pharm/hospital staff/execs/veterans\, lawyers\, VCs\, journalists/editors\, philanthropists\, visiting scientists\, those on sabbaticals\, and others with common interests in biomedical/translational research & discovery/commercialization once a month to casually interact and meet new people over a beverage of their choice and/or appie. It’s a great way for people that have just moved to\, just visiting Vancouver\, looking for collaborations\, jobs\, funding\, connections for start-ups\, networking/socializing to meet others in medicine/research/bioengineering/industry. All are welcome! \nThis event’s sponsor is Blakes. Blakes has provided legal counsel for many in the life sciences industry and has been a great supporter of the BC Biotech landscape for many years.
URL:https://scienceinvancouver.com/event/d-r-i-n-k-s-vancouver-5-2/
LOCATION:Mahony and Sons\, 601 Stamps Landing\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221027T160000
DTEND;TZID=America/Vancouver:20221027T183000
DTSTAMP:20260403T182205
CREATED:20221027T164740Z
LAST-MODIFIED:20221027T164740Z
UID:28224-1666886400-1666895400@scienceinvancouver.com
SUMMARY:D.R.I.N.K.S. Vancouver
DESCRIPTION:The D.R.I.N.K.S. (Discussions Relevant to Inspiring New Knowledge and Science) social is held monthly at Mahoneys on Stamps Landing (Old Monk Mcqueens on False Creek at 601 Stamps Landing – http://mahonyandsons.com/). The purpose is to bring together faculty\, clinicians\, engineers\, nurses\, physio/rehab\, scientists\, residents\, trainees\, staff\, entrepreneurs\, bio/pharm/hospital staff/execs/veterans\, lawyers\, VCs\, journalists/editors\, philanthropists\, visiting scientists\, those on sabbaticals\, and others with common interests in biomedical/translational research & discovery/commercialization once a month to casually interact and meet new people over a beverage of their choice and/or appie. It’s a great way for people that have just moved to\, just visiting Vancouver\, looking for collaborations\, jobs\, funding\, connections for start-ups\, networking/socializing to meet others in medicine/research/bioengineering/industry. All are welcome! \nThis event’s sponsor is Blakes. Blakes has provided legal counsel for many in the life sciences industry and has been a great supporter of the BC Biotech landscape for many years.
URL:https://scienceinvancouver.com/event/d-r-i-n-k-s-vancouver-5-3/
LOCATION:Mahony and Sons\, 601 Stamps Landing\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221027T160000
DTEND;TZID=America/Vancouver:20221027T183000
DTSTAMP:20260403T182205
CREATED:20221027T164740Z
LAST-MODIFIED:20221027T164740Z
UID:31307-1666886400-1666895400@scienceinvancouver.com
SUMMARY:D.R.I.N.K.S. Vancouver
DESCRIPTION:The D.R.I.N.K.S. (Discussions Relevant to Inspiring New Knowledge and Science) social is held monthly at Mahoneys on Stamps Landing (Old Monk Mcqueens on False Creek at 601 Stamps Landing – http://mahonyandsons.com/). The purpose is to bring together faculty\, clinicians\, engineers\, nurses\, physio/rehab\, scientists\, residents\, trainees\, staff\, entrepreneurs\, bio/pharm/hospital staff/execs/veterans\, lawyers\, VCs\, journalists/editors\, philanthropists\, visiting scientists\, those on sabbaticals\, and others with common interests in biomedical/translational research & discovery/commercialization once a month to casually interact and meet new people over a beverage of their choice and/or appie. It’s a great way for people that have just moved to\, just visiting Vancouver\, looking for collaborations\, jobs\, funding\, connections for start-ups\, networking/socializing to meet others in medicine/research/bioengineering/industry. All are welcome! \nThis event’s sponsor is Blakes. Blakes has provided legal counsel for many in the life sciences industry and has been a great supporter of the BC Biotech landscape for many years.
URL:https://scienceinvancouver.com/event/d-r-i-n-k-s-vancouver-5-4/
LOCATION:Mahony and Sons\, 601 Stamps Landing\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221027T160000
DTEND;TZID=America/Vancouver:20221027T183000
DTSTAMP:20260403T182205
CREATED:20221027T164740Z
LAST-MODIFIED:20221027T164740Z
UID:32767-1666886400-1666895400@scienceinvancouver.com
SUMMARY:D.R.I.N.K.S. Vancouver
DESCRIPTION:The D.R.I.N.K.S. (Discussions Relevant to Inspiring New Knowledge and Science) social is held monthly at Mahoneys on Stamps Landing (Old Monk Mcqueens on False Creek at 601 Stamps Landing – http://mahonyandsons.com/). The purpose is to bring together faculty\, clinicians\, engineers\, nurses\, physio/rehab\, scientists\, residents\, trainees\, staff\, entrepreneurs\, bio/pharm/hospital staff/execs/veterans\, lawyers\, VCs\, journalists/editors\, philanthropists\, visiting scientists\, those on sabbaticals\, and others with common interests in biomedical/translational research & discovery/commercialization once a month to casually interact and meet new people over a beverage of their choice and/or appie. It’s a great way for people that have just moved to\, just visiting Vancouver\, looking for collaborations\, jobs\, funding\, connections for start-ups\, networking/socializing to meet others in medicine/research/bioengineering/industry. All are welcome! \nThis event’s sponsor is Blakes. Blakes has provided legal counsel for many in the life sciences industry and has been a great supporter of the BC Biotech landscape for many years.
URL:https://scienceinvancouver.com/event/d-r-i-n-k-s-vancouver-5-5/
LOCATION:Mahony and Sons\, 601 Stamps Landing\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260403T182205
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:32761-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260403T182205
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:24279-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260403T182205
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:26603-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260403T182205
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:28218-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221026T110000
DTEND;TZID=America/Vancouver:20221026T120000
DTSTAMP:20260403T182205
CREATED:20221003T164219Z
LAST-MODIFIED:20221003T164219Z
UID:31301-1666782000-1666785600@scienceinvancouver.com
SUMMARY:Know Your Payers: Will Insurers Pay for Your Health Technology?
DESCRIPTION:Understanding how private insurance companies and publicly funded health systems decide which health technologies to pay for and how much they are willing to pay for them is a critical part of a successful commercialization strategy. Health Technology Assessment (or HTA) is an evaluation process that provides payers with recommendations on when\, and at what price\, a technology should be made available to a given patient population. \nThis webinar will provide an overview of HTA\, including explanations of key concepts like economic evaluation\, cost-effectiveness analysis\, incremental cost-effectiveness ratios and quality-adjusted life years. \nFollowing the webinar\, participants will be able to explain how and why health systems use HTA\, describe the assumptions and evidence necessary to quantify the value-for-money of a new health technology\, and define a set of key HTA concepts.
URL:https://scienceinvancouver.com/event/know-your-payers-will-insurers-pay-for-your-health-technology-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260403T182205
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:24128-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260403T182205
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:26598-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine-2/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260403T182205
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:28213-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine-3/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260403T182205
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:31296-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine-4/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221025T160000
DTEND;TZID=America/Vancouver:20221025T210000
DTSTAMP:20260403T182205
CREATED:20220920T203908Z
LAST-MODIFIED:20220920T203908Z
UID:32756-1666713600-1666731600@scienceinvancouver.com
SUMMARY:The Future of Regenerative Medicine
DESCRIPTION:Centre for Commercialization of Regenerative Medicine (CCRM) and Creative Destruction Lab (CDL) invite you to join a Speaker Event and Dinner focusing on The Future of Regenerative Medicine. \nThe evening will kick off with three keynote speakers who are leaders in the advanced therapies space\, followed by a moderated panel featuring innovators on the forefront of regenerative medicine\, and ending with a night of networking. \nDetails\n\nDate: Tuesday\, October 25\, 2022\nRegistration: 3:30-4:00 PM PT\nTime: 4:00 PM-9:00 PM PT\nLocation: Pan Pacific Hotel; 999 Canada Pl #300\, Vancouver\, BC V6C 3B5\nTicket Pricing: \n\nEarly Bird (until Sept 30): $120\nGeneral Admission (from Oct 1-18): $200\nTickets to this event include two drink tickets during cocktail hour and a three-course plated dinner.\n\n\n\nKeynote Speakers\nMichael May – President & Chief Executive Officer\, Centre for Commercialization of Regenerative Medicine (CCRM)\nMichael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM)\, a Canadian\, not-for-profit that develops technologies\, launches new companies\, and catalyzes investment in the field of regenerative medicine\, including cell and gene therapy. Prior to CCRM\, Michael was the President\, and co-founder\, of Rimon Therapeutics Ltd.\, a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity. Dr. May completed his PhD in Chemical Engineering at the University of Toronto as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. \nAli Tehrani – Venture Partner\, Amplitude Ventures\nAli Tehrani co-founded Zymeworks\, a phase 3 clinical-stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers\, in 2003 and led the company from inception to clinical validation\, through an IPO on the NYSE\, to peak $1.9B valuation and 500 employees across Vancouver Canada and Seattle. Dr. Tehrani has a BASc and M.S. in Biochemistry from the University of Massachusetts Amherst and his PhD in Microbiology and Immunology from the University of British Columbia. \nPeter Zandstra – Director\, School of BME & Michael Smith Labs\, UBC; CSO-CCRM; Founder and CSO Notch Therapeutics\nPeter Zandstra is a serial entrepreneur and Founding Director of the School of Biomedical Engineering at the University of British Columbia and is the Director of the Michael Smith Laboratories. Dr. Zandstra founded ExCellThera\, an advanced clinical-stage biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use\, and Notch Therapeutics\, the developer of a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems. Previously\, Dr. Zandstra co-founded the CCRM while a Professor at the University of Toronto and still holds the Chief Scientific Officer position. Earlier this year\, Dr. Zandstra was appointed to the 2021 Order of Canada. \nCDL Advanced Therapies\nCDL has launched a new Advanced Therapies stream for pre-seed and seed-stage ventures at the forefront of biotech. To bring this program to life\, CDL has partnered with CCRM\, a leader in accelerating the development and commercialization of regenerative medicine-based technologies. Four world-class CDL locations play host to CDL Advanced Therapies – the University of British Columbia\, the University of Oxford\, the University of Toronto\, and the University of Wisconsin-Madison – creating an international network that will foster the next generation of biotech companies. \nThe Advanced Therapies global stream admits an annual cohort of pre-Seed and Seed stage startups. The program brings together entrepreneurs\, investors\, and scientists with expertise building scalable companies in a variety of fields related to biology\, medicine\, and healthcare. Read more
URL:https://scienceinvancouver.com/event/the-future-of-regenerative-medicine-5/
LOCATION:Pan Pacific Hotel\, 999 Canada Pl #300\, Vancouver\, BC\, V6C 3B5\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260403T182205
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:32764-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin-5/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260403T182205
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:24324-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260403T182205
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:26606-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin-2/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260403T182206
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:28221-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin-3/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20221019T120000
DTEND;TZID=America/Vancouver:20221019T130000
DTSTAMP:20260403T182206
CREATED:20221004T164745Z
LAST-MODIFIED:20221004T164745Z
UID:31304-1666180800-1666184400@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Annalijn Conklin
DESCRIPTION:Annalijn Conklin\, PhD (Cantab.)\, MPH\, MSc (Research)\, BSc (Hons)\nScientist\, CHÉOS\nAssistant Professor\, Faculty of Pharmaceutical Sciences\, UBC \nPartnering with patients on surgical PREhabilitation for better patient outcomes (PREP) \nPrehab is a promising but untapped strategy for abdominal operations to improve post-surgical outcomes and reduce costs — a top policy and research priority. The logic for ‘prehab’ is sufficiently compelling that expert consensus calls for a ‘bundle of care’ addressing multiple modifiable behavioural risk factors to provide stronger benefits to patients through synergistic effects on health\, and ‘prehab’ is currently being piloted in Eastern Canada and Spain. This patient-oriented feasibility study co-developed a web-based prehabilitation program with six patient partners to support colorectal surgery patients in better preparing for surgery. The new patient education website covered key lifestyle modifications\, their role in surgical outcomes\, and relevant resources for both colorectal cancer and non-cancer patients waiting for surgery\, with content drawn from expert-vetted sources\, including our scientific team. We then recruited 25 patients between January and September 2021 to explore the feasibility of providing a web-based intervention of structured support as ‘prehab’ for patients preparing for colorectal cancer surgery in BC. Our results showed that there was high demand and good acceptability of the surgical ‘prehab’ programme involving online structured self-management support\, but there was limited practicality for a telephone-based Health Coach as this service was never requested by patients despite reported interest. Our secondary research question of whether there is promise for success in improving overall patient wellbeing was not supported by the three-month follow-up health-related quality of life survey. The results of this study enabled the decision by the surgeons at PHC’s Colorectal Clinic to permanently adopt this patient-oriented website and integrate it into clinical care. \nThis is a hybrid event\, you may attend in person or virtually. Please register and indicate your preference. Click here to register (required): https://ubc.zoom.us/meeting/register/u5cocOCorTIsGdRP6zf5XWZ9PNms9mLR6mnH
URL:https://scienceinvancouver.com/event/wip-seminar-dr-annalijn-conklin-4/
LOCATION:St. Paul’s Hospital & Online\, 1081 Burrard St\, Vancouver\, BC\, V6Z 1Y6\, Canada
END:VEVENT
END:VCALENDAR